Biopharma Plazma LLC (manufacturing, primary packaging (ampoules), secondary packaging (ampoules, syringes), quality control, batch release)

Ukraine

All drugs from this manufacturer

  • RESOGLOBINE

    The drug is used for the prevention of Rh sensitization in Rh-negative women. It is prescribed during pregnancy (in case of threat of miscarriage, amniocentesis, abdominal trauma), after childbirth (if the baby is Rh-positive), as well as in cases of induced abortion.

    Dosage form: solution for injection

    Active substance Dosage
    specific antibodies to anti-rh0(d) 1500 IU 300 mcg immunoglobulin ml

    ATC: J06BB01

  • RESOGLOGIN

    The drug is used for the prevention of Rh incompatibility in Rh-negative women. It is prescribed during pregnancy (before childbirth, in case of threat of miscarriage, amniocentesis, or abdominal trauma), after childbirth, as well as in cases of induced abortion.

    Dosage form: solution for injection

    Active substance Dosage
    specific antibodies to anti-rh0(d) 1500 IU (300 mcg immunoglobulin)

    ATC: J06BB01